Federation Bio Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of FB-001 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria (NCT05650112) | Federation Bio Inc. | 2022-11-16 |
Track Federation Bio Inc. automatically
Every clearance here is in the API, with alerts when new ones post.